Hari Krishna Ananthula

1.6k total citations · 1 hit paper
5 papers, 1.1k citations indexed

About

Hari Krishna Ananthula is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Infectious Diseases. According to data from OpenAlex, Hari Krishna Ananthula has authored 5 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Oncology, 2 papers in Public Health, Environmental and Occupational Health and 1 paper in Infectious Diseases. Recurrent topics in Hari Krishna Ananthula's work include Gastroesophageal reflux and treatments (1 paper), Corneal Surgery and Treatments (1 paper) and Drug Transport and Resistance Mechanisms (1 paper). Hari Krishna Ananthula is often cited by papers focused on Gastroesophageal reflux and treatments (1 paper), Corneal Surgery and Treatments (1 paper) and Drug Transport and Resistance Mechanisms (1 paper). Hari Krishna Ananthula collaborates with scholars based in United States. Hari Krishna Ananthula's co-authors include Ripal Gaudana, Ashwin C. Parenky, Ashim K. Mitra, Deep Kwatra, Ashim K. Mitra, Dhananjay Pal, Iwao Ojima, Melanie T. Cushion, Michael J. Linke and Maurizio Del Poeta and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, International Journal of Pharmaceutics and The AAPS Journal.

In The Last Decade

Hari Krishna Ananthula

5 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ocular Drug Delivery

2010 999 citations Ripal Gaudana, Hari Krishna Ananthula et al. The AAPS Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hari Krishna Ananthula United States	5	534	495	313	284	279	5	1.1k
Kishore Cholkar United States	16	452 0.8×	349 0.7×	234 0.7×	383 1.3×	214 0.8×	28	1.1k
Ashwin C. Parenky United States	6	560 1.0×	495 1.0×	325 1.0×	315 1.1×	309 1.1×	9	1.1k
Ankita R. Desai United States	16	557 1.0×	631 1.3×	215 0.7×	105 0.4×	288 1.0×	21	1.0k
Ripal Gaudana United States	9	869 1.6×	713 1.4×	443 1.4×	469 1.7×	416 1.5×	14	1.6k
Mary Joseph India	11	251 0.5×	236 0.5×	262 0.8×	310 1.1×	229 0.8×	31	942
Sriram Gunda United States	14	245 0.5×	170 0.3×	191 0.6×	213 0.8×	120 0.4×	18	669
Jayamanti Pandit India	12	492 0.9×	150 0.3×	103 0.3×	211 0.7×	92 0.3×	20	792
Jean‐Sébastien Garrigue France	24	751 1.4×	1.3k 2.6×	589 1.9×	163 0.6×	628 2.3×	68	1.8k
Xurxo García‐Otero Spain	11	275 0.5×	198 0.4×	169 0.5×	144 0.5×	126 0.5×	23	598
Peter W. J. Morrison United Kingdom	9	419 0.8×	370 0.7×	136 0.4×	167 0.6×	195 0.7×	9	767

Countries citing papers authored by Hari Krishna Ananthula

Since Specialization

Citations

This map shows the geographic impact of Hari Krishna Ananthula's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hari Krishna Ananthula with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hari Krishna Ananthula more than expected).

Fields of papers citing papers by Hari Krishna Ananthula

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hari Krishna Ananthula. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hari Krishna Ananthula. The network helps show where Hari Krishna Ananthula may publish in the future.

Co-authorship network of co-authors of Hari Krishna Ananthula

This figure shows the co-authorship network connecting the top 25 collaborators of Hari Krishna Ananthula. A scholar is included among the top collaborators of Hari Krishna Ananthula based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hari Krishna Ananthula. Hari Krishna Ananthula is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Chawla, Akshita, Azher Hussain, Huub Jan Kleijn, et al.. (2023). Population pharmacokinetic analysis of the P2X3‐receptor antagonist gefapixant. CPT Pharmacometrics & Systems Pharmacology. 12(8). 1107–1118. 5 indexed citations

2.

Ananthula, Hari Krishna, Scott Parker, R. Mark L. Buller, et al.. (2018). Preclinical pharmacokinetic evaluation to facilitate repurposing of tyrosine kinase inhibitors nilotinib and imatinib as antiviral agents. BMC Pharmacology and Toxicology. 19(1). 80–80. 12 indexed citations

3.

Haranahalli, Krupanandan, Robert Rieger, Hari Krishna Ananthula, et al.. (2018). Acylhydrazones as Antifungal Agents Targeting the Synthesis of Fungal Sphingolipids. Antimicrobial Agents and Chemotherapy. 62(5). 54 indexed citations

4.

Gaudana, Ripal, Hari Krishna Ananthula, Ashwin C. Parenky, & Ashim K. Mitra. (2010). Ocular Drug Delivery. The AAPS Journal. 12(3). 348–360. 999 indexed citations breakdown →

5.

Kwatra, Deep, et al.. (2009). Identification and functional characterization of breast cancer resistance protein in human bronchial epithelial cells (Calu-3). International Journal of Pharmaceutics. 384(1-2). 32–38. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact